Effect of growth hormone in IVF protocol

Phase 2

• Conditions: infertility.; Female infertility

• Registration Number: IRCT201107296420N6
• Lead Sponsor: Yazd research and clinical center for infertility

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

history of one or more failed in IVF cycles which three or fewer oocytes were been retrieved; serum steradiol’s level in day of HCG injection <500 pg/ml; FSH in day 3 of cycle >10 and age>40 years. Exclusion criteria: Body mass index higher than 30; endocrine or metabolic disorder; endometriosis and severe male factor (azospermia ).

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Chemical pregnancy. Timepoint: 2 weeks. Method of measurement: serum BHCG.

Secondary Outcome Measures

Name	Time	Method
umber of oocyte. Timepoint: 15 days. Method of measurement: numberring.;Number of gonadotropin ampuls. Timepoint: 15 days. Method of measurement: numberring.